Literature DB >> 16493618

Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.

Kaaren K Reichard1, Qian-Yun Zhang, Lorraine Sanchez, John Hozier, David Viswanatha, Kathryn Foucar.   

Abstract

We report a case of donor-derived acute myeloid leukemia (AML) occurring in a 33-year-old man after allogeneic bone marrow transplantation (BMT) for precursor T-cell acute lymphoblastic -leukemia (T-ALL). The cells for BMT were from his human leukocyte antigen (HLA)-matched sister. Fluorescence in-situ hybridization (FISH) analysis showed the AML to be of donor origin (i.e., karyotypically female) with an 11q23 (mixed lineage leukemia (MLL) gene) translocation, while the original T-ALL exhibited a male karyotype with abnormalities of chromosomes 6, 8, and a t(10;14)(q24;q11.2). Subsequent molecular short tandem repeat studies confirmed the AML to be of donor origin. Donor-cell leukemia (DCL) after allogeneic BMT is a rare, yet well-documented, event. Our report presents clinicopathologic information about a case of DCL and a review of the recent literature.

Entities:  

Mesh：

Year:  2006        PMID： 16493618     DOI： 10.1002/ajh.20389

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  18 in total

1.  Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Authors:  Nirali N Shah; Ulrike Bacher; Terry Fry; Katherine R Calvo; Maryalice Stetler-Stevenson; Diane C Arthur; Roger Kurlander; Kristin Baird; Barbara Wise; Sergio Giralt; Michael Bishop; Nancy M Hardy; Alan S Wayne
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 2.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

3.  Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Authors:  Robbie G Majzner; Huzefa Mogri; Ravi Varadhan; Patrick Brown; Kenneth R Cooke; Javier Bolaños-Meade; Lode Swinnen; Jennifer Kanakry; Leo Luznik; Richard J Jones; Ephraim Fuchs; Rich Ambinder; Yvette Kasamon; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-03       Impact factor: 5.742

Review 4.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

5.  Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

6.  Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.

Authors:  Noelle V Frey; Christopher E Leid; Peter C Nowell; Ewa Tomczak; Honore T Strauser; Margaret Kasner; Steven Goldstein; Alison Loren; Edward Stadtmauer; Selina Luger; Elizabeth Hexner; Joanne Hinkle; David L Porter
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

7.  Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary.

Authors:  J M Watts; X V Wang; R T Swords; E Paietta; D Douer; S M Lugar; H F Fernandez; J M Rowe; H M Lazarus; M S Tallman; M R Litzow
Journal:  Bone Marrow Transplant       Date:  2016-03-14       Impact factor: 5.483

8.  Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.

Authors:  Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro; Keiichi Nemoto
Journal:  Int J Hematol       Date:  2009-08-20       Impact factor: 2.490

9.  Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.

Authors:  Gulsun Erdag; Jeanne M Meck; Aurelia Meloni-Ehrig; Ludmila Matyakhina; Theresa Donohue; Ramaprasad Srinivasan; Philip Mowrey; JoAnn Kelly; Aleah Smith; Richard Childs
Journal:  Cancer Genet Cytogenet       Date:  2009-04-15

10.  Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.

Authors:  Toshinori Kondo; Taizo Tasaka; Risa Shimizu; Kiyohito Hayashi; Seiko Yamada; Hirofumi Fukuda; Tadashi Hirose; Asako Takeuchi; Fuminori Sano; Hirotoshi Tokunaga; Yoshiko Matsuhashi; Hideho Wada
Journal:  Mol Clin Oncol       Date:  2020-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.